nimbolide has been researched along with Colorectal Neoplasms in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Andrijauskaite, K; Morris, J; Qiu, Z; Wargovich, MJ | 1 |
| Aggarwal, BB; Gupta, SC; Mo, YY; Nair, MS; Prasad, S; Sethumadhavan, DR | 1 |
2 other study(ies) available for nimbolide and Colorectal Neoplasms
| Article | Year |
|---|---|
Disruption of Epigenetic Silencing in Human Colon Cancer Cells Lines Utilizing a Novel Supercritical CO
Topics: Azadirachta; Carbon Dioxide; Cell Line, Tumor; Cell Proliferation; Colorectal Neoplasms; DNA Methylation; Epigenesis, Genetic; HCT116 Cells; HT29 Cells; Humans; Limonins; Plant Extracts; Plant Leaves | 2019 |
Nimbolide, a limonoid triterpene, inhibits growth of human colorectal cancer xenografts by suppressing the proinflammatory microenvironment.
Topics: Animals; Antineoplastic Agents, Phytogenic; Apoptosis; Cell Line, Tumor; Cell Proliferation; Colorectal Neoplasms; Disease Models, Animal; Enzyme Activation; Gene Expression Regulation, Neoplastic; Humans; Limonins; Mice; NF-kappa B; STAT3 Transcription Factor; Tumor Burden; Tumor Microenvironment; Xenograft Model Antitumor Assays | 2013 |